2018 Barriers of the CNS Gordon Research Conference and Gordon Research Seminar
2018 CNS戈登研究会议和戈登研究研讨会的障碍
基本信息
- 批准号:9542556
- 负责人:
- 金额:$ 2.39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-03-01 至 2019-02-28
- 项目状态:已结题
- 来源:
- 关键词:AddressAlzheimer&aposs DiseaseBioinformaticsBiomedical EngineeringBloodBlood - brain barrier anatomyBlood CirculationBrainBrain NeoplasmsCentral Nervous System DiseasesClinicalCollaborationsCommunitiesComplexComputer SimulationDevelopmentDiagnosisDiagnosticDiseaseDrug Delivery SystemsEnvironmentEpithelialFacultyFeedbackFosteringFundingGoalsGrowth and Development functionHealthHomeostasisImmune systemInternationalKnowledgeLeadMaintenanceMeasuresMentorsMentorshipMetastatic malignant neoplasm to brainMethodsMolecularNeuraxisNew HampshireParticipantPharmaceutical PreparationsPostdoctoral FellowPublic HealthRegulationRequest for ApplicationsRequest for ProposalsResearchResearch MethodologyResearch PersonnelRoleScienceScientistSenior ScientistStructureStudentsTechnologyTherapeuticcareercollegedata miningfluid flowgenetic signatureimprovedinnovationinsightinterestintravital microscopymathematical modelmeetingsmultidisciplinarynervous system disorderneurotoxicnew technologynovelnovel strategiespalliativepeerposterspreventsymposiumtranscriptometumor growth
项目摘要
Project Summary / Abstract
This proposal requests support for partial funding of the 2018 “Barriers of the Central Nervous System
(CNS)” GRC and GRS that will be held at Colby Sawyer College, New Hampshire, on June 16-17, 2018
(GRS) and June 17-22, 2018 (GRC). The overall goal of this international conference is to improve
understanding of the highly complex cellular and molecular mechanisms regulating the function of the
endothelial (e.g. blood-brain barrier (BBB)) and epithelial (e.g. blood-CSF barrier (BCSFB)) brain barriers in
development, maintenance and disease. The 2018 meetings will achieve this goal by covering major aspects
of CNS barrier sciences and by making a special effort to include novel research methodology such as
advanced intravital microscopy, mathematical modelling, bioinformatics and bioengineering; which will allow
participants to obtain insights in brain barrier function from novel angles. This interdisciplinary knowledge
exchange will be fostered by invited talks and daily poster presentations.
The meeting will start with a keynote session on the role of the brain barriers in regulating CNS immune
privilege and conclude with a trendsetting keynote session on chip technology for bioengineering the brain
barriers. An additional 7 sessions will address: i) the role of brain barriers in CNS fluid flow, ii) the brain barriers
in development and homeostasis, iii) brain barriers bioinformatics including introduction of a novel data-mining
platform, the BBBHub, iv) molecular mechanisms regulating barrier integrity, v) the role of brain barriers in
tumor growth and brain metastases, vi) novel concepts in drug delivery across the brain barriers, and, vii) brain
barrier microenvironment in health and disease.
The GRC Barriers of the CNS stands out from other brain barriers conferences by bringing together a
multidisciplinary group of senior and junior, academic and non-academic, basic and clinical scientists from
around the world. The conference provides a protected environment for presenting ongoing and unpublished
research promoting new ideas and novel interdisciplinary and translational collaborations.
The preceding 2-day “Barriers” GRS is organized by junior investigators at the postdoctoral level and is
intended to introduce younger scientists (postgraduate students, post-docs, junior faculty) to the field's
methods and issues and to facilitate networking and provide mentorship opportunities.
This application addresses a major public health concern, diseases of the CNS. Improving our knowledge
regarding brain barrier structure and function is prerequisite to overcome these barriers to achieve appropriate
diagnosis and therapy of neurological disorders ranging from brain tumors to Alzheimer's disease, which is
presently limited to symptomatic and palliative measures. Instructing young researchers to think of innovative
and novel solutions and to bridge disciplinary interfaces will advance the capacity to bring new approaches to
realize the untapped potential for the treatment of CNS disease.
项目总结/摘要
该提案要求支持2018年“中枢神经系统障碍”的部分资金
(CNS)“GRC和GRS将于2018年6月16日至17日在新罕布什尔州的科尔比索耶学院举行
(GRS)和2018年6月17日至22日(GRC)。本次国际会议的总体目标是提高
了解调节细胞功能的高度复杂的细胞和分子机制,
内皮(例如血脑屏障(BBB))和上皮(例如血-CSF屏障(BCSFB))脑屏障,
发育、维持和疾病。2018年的会议将通过涵盖主要方面来实现这一目标
的CNS屏障科学,并作出特别努力,包括新的研究方法,
先进的活体显微镜,数学建模,生物信息学和生物工程;这将使
参与者从新的角度获得对脑屏障功能的见解。这种跨学科的知识
并会透过邀请讲座及每日海报展示,促进交流。
会议将以关于脑屏障在调节CNS免疫中的作用的主题会议开始,
特权和结束与芯片技术的生物工程大脑的趋势基调会议
隔栏.另外7个会议将讨论:i)脑屏障在CNS液体流动中的作用,ii)脑屏障
在发展和体内平衡,三)大脑障碍生物信息学,包括引进一种新的数据挖掘
平台,BBBHub,iv)调节屏障完整性的分子机制,v)脑屏障在
肿瘤生长和脑转移,vi)穿过脑屏障的药物递送的新概念,和,vii)脑
健康和疾病中的屏障微环境。
CNS的GRC屏障从其他脑屏障会议中脱颖而出,汇集了一个
多学科小组的高级和初级,学术和非学术,基础和临床科学家从
世界各地会议提供了一个受保护的环境,
研究促进新的想法和新的跨学科和翻译合作。
前两天的“障碍”GRS由博士后水平的初级研究者组织,
旨在介绍年轻的科学家(研究生,博士后,初级教师)到该领域的
方法和问题,并促进联网和提供指导机会。
本申请解决了一个主要的公共卫生问题,CNS疾病。提高我们的知识
了解脑屏障的结构和功能是克服这些障碍,实现适当的
诊断和治疗神经系统疾病,从脑肿瘤到阿尔茨海默病,
目前仅限于对症和姑息措施。指导年轻研究人员思考创新
和新的解决方案和桥梁学科接口将提高能力,使新的方法,
实现治疗CNS疾病的未开发潜力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
William Elmquist其他文献
William Elmquist的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('William Elmquist', 18)}}的其他基金
Influence of Anti-Angiogenic Therapy on Drug Delivery to Brain Tumors
抗血管生成治疗对脑肿瘤药物输送的影响
- 批准号:
8554379 - 财政年份:2012
- 资助金额:
$ 2.39万 - 项目类别:
Influence of Anti-Angiogenic Therapy on Drug Delivery to Brain Tumors
抗血管生成治疗对脑肿瘤药物输送的影响
- 批准号:
8711598 - 财政年份:2012
- 资助金额:
$ 2.39万 - 项目类别:
Influence of Anti-Angiogenic Therapy on Drug Delivery to Brain Tumors
抗血管生成治疗对脑肿瘤药物输送的影响
- 批准号:
9105773 - 财政年份:2012
- 资助金额:
$ 2.39万 - 项目类别:
Influence of Anti-Angiogenic Therapy on Drug Delivery to Brain Tumors
抗血管生成治疗对脑肿瘤药物输送的影响
- 批准号:
8900366 - 财政年份:2012
- 资助金额:
$ 2.39万 - 项目类别:
Influence of Anti-Angiogenic Therapy on Drug Delivery to Brain Tumors
抗血管生成治疗对脑肿瘤药物输送的影响
- 批准号:
8436561 - 财政年份:2012
- 资助金额:
$ 2.39万 - 项目类别:
Influence of Anti-Angiogenic Therapy on Drug Delivery to Brain Tumors
抗血管生成治疗对脑肿瘤药物输送的影响
- 批准号:
8702251 - 财政年份:2012
- 资助金额:
$ 2.39万 - 项目类别:
Improving Delivery of Molecularly-Targeted Therapy to Invasive Glioma Cells
改善侵袭性胶质瘤细胞的分子靶向治疗
- 批准号:
8434913 - 财政年份:2010
- 资助金额:
$ 2.39万 - 项目类别: